MeiraGTx Holdings

MGTX · NASDAQ

$9.97+$0.52 (+5.50%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $9.45

Latest news

Press releaseAug 26, 10:49 AM ETPRNewswire
Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical
NewsAug 13, 8:40 AM ET
MeiraGTx Hldgs Q2 EPS $1.71 Beats $(0.46) Estimate, Sales $321.434M Beat $12.476M Estimate
Press releaseAug 13, 8:00 AM ETGlobe Newswire
MeiraGTx Reports Second Quarter 2026 Financial and Operational Results
Press releaseAug 11, 10:30 AM ETPRNewswire
Graviton BioScience Announces Clearance of Investigational New Drug (IND) for GV101 for the Treatment of Friedreich's Ataxia
Press releaseJul 7, 7:30 AM ETGlobe Newswire
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)
Press releaseMay 14, 8:00 AM ETGlobe Newswire
MeiraGTx Reports First Quarter 2026 Financial and Operational Results
NewsApr 16, 1:06 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsApr 16, 10:16 AM ETVandana Singh
Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson
NewsApr 16, 8:07 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsApr 16, 7:16 AM ET
MeiraGTx Enters Into Asset Purchase Agreement With Johnson & Johnson To Buy All Interests In Bota-Vec For Treatment Of XLRP; MeiraGTx To Pay J&J $25M Upfront, Milestone Fees, High Double‑Digit Royalties On Bota‑Vec Sales
Press releaseApr 16, 7:10 AM ETGlobe Newswire
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
Press releaseApr 16, 7:00 AM ETGlobe Newswire
MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia
Press releaseApr 14, 8:30 AM ETGlobe Newswire
MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026
NewsMar 26, 8:26 AM ET
MeiraGTx Hldgs Q4 EPS $0.19 Beats $(0.61) Estimate, Sales $75.364M Beat $3.869M Estimate
Press releaseMar 26, 8:00 AM ETGlobe Newswire
MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results
Press releaseFeb 17, 8:30 AM ETGlobe Newswire
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
Press releaseFeb 3, 8:00 AM ETPRNewswire
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy
Press releaseNov 20, 3:00 PM ETPRNewswire
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference
Press releaseNov 13, 8:00 AM ETGlobe Newswire
MeiraGTx Reports Third Quarter 2025 Financial and Operational Results
NewsNov 10, 9:11 AM ETVandana Singh
Eli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration
NewsNov 10, 7:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseAug 14, 8:00 AM ETGlobe Newswire
MeiraGTx Reports Second Quarter 2025 Financial and Operational Results
NewsMar 13, 1:06 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsMar 13, 12:25 PM ETAvi Kapoor
Crude Oil Falls 1%; Dollar General Posts Upbeat Sales
NewsMar 13, 10:09 AM ETAvi Kapoor
G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday
NewsMar 13, 8:09 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseNov 24, 7:27 PM ETPRNewswire
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
NewsNov 8, 10:30 AM ETAvi Kapoor
Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good
NewsOct 15, 2:14 PM ETAvi Kapoor
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
NewsOct 15, 11:57 AM ETAvi Kapoor
Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views
NewsOct 15, 10:46 AM ETAvi Kapoor
Walgreens Posts Upbeat Earnings, Joins Wolfspeed, Ericsson And Other Big Stocks Moving Higher On Tuesday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical

MeiraGTx Hldgs Q2 EPS $1.71 Beats $(0.46) Estimate, Sales $321.434M Beat $12.476M Estimate

MeiraGTx Reports Second Quarter 2026 Financial and Operational Results

Graviton BioScience Announces Clearance of Investigational New Drug (IND) for GV101 for the Treatment of Friedreich's Ataxia

MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)

MeiraGTx Reports First Quarter 2026 Financial and Operational Results

12 Health Care Stocks Moving In Thursday's Intraday Session

Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson

12 Health Care Stocks Moving In Thursday's Pre-Market Session

MeiraGTx Enters Into Asset Purchase Agreement With Johnson & Johnson To Buy All Interests In Bota-Vec For Treatment Of XLRP; MeiraGTx To Pay J&J $25M Upfront, Milestone Fees, High Double‑Digit Royalties On Bota‑Vec Sales

MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia

MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026

MeiraGTx Hldgs Q4 EPS $0.19 Beats $(0.61) Estimate, Sales $75.364M Beat $3.869M Estimate

MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results

Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A

ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy

Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference

MeiraGTx Reports Third Quarter 2025 Financial and Operational Results

Eli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration

12 Health Care Stocks Moving In Monday's Pre-Market Session

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

12 Health Care Stocks Moving In Thursday's Intraday Session

Crude Oil Falls 1%; Dollar General Posts Upbeat Sales

G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good

Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results

Crude Oil Tumbles 5%; Goldman Sachs Earnings Top Views

Walgreens Posts Upbeat Earnings, Joins Wolfspeed, Ericsson And Other Big Stocks Moving Higher On Tuesday